node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
CTAGE8 | DEFB104A | ENSP00000417289 | ENSP00000320813 | CTAGE family, member 8 | defensin, beta 104A; Has antimicrobial activity. Synergistic effects with lysozyme and DEFB103 | 0.540 |
CTAGE8 | POTEG | ENSP00000417289 | ENSP00000386971 | CTAGE family, member 8 | POTE ankyrin domain family, member G | 0.562 |
CTAGE8 | SERF1B | ENSP00000417289 | ENSP00000370126 | CTAGE family, member 8 | small EDRK-rich factor 1B (centromeric) | 0.537 |
DEFB104A | CTAGE8 | ENSP00000320813 | ENSP00000417289 | defensin, beta 104A; Has antimicrobial activity. Synergistic effects with lysozyme and DEFB103 | CTAGE family, member 8 | 0.540 |
DEFB104A | POTEG | ENSP00000320813 | ENSP00000386971 | defensin, beta 104A; Has antimicrobial activity. Synergistic effects with lysozyme and DEFB103 | POTE ankyrin domain family, member G | 0.562 |
DEFB104A | SERF1B | ENSP00000320813 | ENSP00000370126 | defensin, beta 104A; Has antimicrobial activity. Synergistic effects with lysozyme and DEFB103 | small EDRK-rich factor 1B (centromeric) | 0.538 |
NAIP | SERF1B | ENSP00000428657 | ENSP00000370126 | NLR family, apoptosis inhibitory protein; Anti-apoptotic protein which acts by inhibiting the activities of CASP3, CASP7 and CASP9. Can inhibit the autocleavage of pro-CASP9 and cleavage of pro-CASP3 by CASP9. Capable of inhibiting CASP9 autoproteolysis at ’Asp-315’ and decreasing the rate of auto proteolysis at ’Asp-330’. Acts as a mediator of neuronal survival in pathological conditions. Prevents motor- neuron apoptosis induced by a variety of signals. Possible role in the prevention of spinal muscular atrophy that seems to be caused by inappropriate persistence of motor-neuron apopt [...] | small EDRK-rich factor 1B (centromeric) | 0.500 |
NAIP | SMN1 | ENSP00000428657 | ENSP00000370083 | NLR family, apoptosis inhibitory protein; Anti-apoptotic protein which acts by inhibiting the activities of CASP3, CASP7 and CASP9. Can inhibit the autocleavage of pro-CASP9 and cleavage of pro-CASP3 by CASP9. Capable of inhibiting CASP9 autoproteolysis at ’Asp-315’ and decreasing the rate of auto proteolysis at ’Asp-330’. Acts as a mediator of neuronal survival in pathological conditions. Prevents motor- neuron apoptosis induced by a variety of signals. Possible role in the prevention of spinal muscular atrophy that seems to be caused by inappropriate persistence of motor-neuron apopt [...] | survival of motor neuron 1, telomeric; The SMN complex plays an essential role in spliceosomal snRNP assembly in the cytoplasm and is required for pre-mRNA splicing in the nucleus. It may also play a role in the metabolism of snoRNPs | 0.676 |
NAIP | SMN2 | ENSP00000428657 | ENSP00000370119 | NLR family, apoptosis inhibitory protein; Anti-apoptotic protein which acts by inhibiting the activities of CASP3, CASP7 and CASP9. Can inhibit the autocleavage of pro-CASP9 and cleavage of pro-CASP3 by CASP9. Capable of inhibiting CASP9 autoproteolysis at ’Asp-315’ and decreasing the rate of auto proteolysis at ’Asp-330’. Acts as a mediator of neuronal survival in pathological conditions. Prevents motor- neuron apoptosis induced by a variety of signals. Possible role in the prevention of spinal muscular atrophy that seems to be caused by inappropriate persistence of motor-neuron apopt [...] | survival of motor neuron 2, centromeric | 0.599 |
OR4Q3 | POTEG | ENSP00000330049 | ENSP00000386971 | olfactory receptor, family 4, subfamily Q, member 3; Odorant receptor (Potential) | POTE ankyrin domain family, member G | 0.561 |
OR4Q3 | SERF1B | ENSP00000330049 | ENSP00000370126 | olfactory receptor, family 4, subfamily Q, member 3; Odorant receptor (Potential) | small EDRK-rich factor 1B (centromeric) | 0.468 |
POTEG | CTAGE8 | ENSP00000386971 | ENSP00000417289 | POTE ankyrin domain family, member G | CTAGE family, member 8 | 0.562 |
POTEG | DEFB104A | ENSP00000386971 | ENSP00000320813 | POTE ankyrin domain family, member G | defensin, beta 104A; Has antimicrobial activity. Synergistic effects with lysozyme and DEFB103 | 0.562 |
POTEG | OR4Q3 | ENSP00000386971 | ENSP00000330049 | POTE ankyrin domain family, member G | olfactory receptor, family 4, subfamily Q, member 3; Odorant receptor (Potential) | 0.561 |
POTEG | SERF1B | ENSP00000386971 | ENSP00000370126 | POTE ankyrin domain family, member G | small EDRK-rich factor 1B (centromeric) | 0.554 |
SERF1B | CTAGE8 | ENSP00000370126 | ENSP00000417289 | small EDRK-rich factor 1B (centromeric) | CTAGE family, member 8 | 0.537 |
SERF1B | DEFB104A | ENSP00000370126 | ENSP00000320813 | small EDRK-rich factor 1B (centromeric) | defensin, beta 104A; Has antimicrobial activity. Synergistic effects with lysozyme and DEFB103 | 0.538 |
SERF1B | NAIP | ENSP00000370126 | ENSP00000428657 | small EDRK-rich factor 1B (centromeric) | NLR family, apoptosis inhibitory protein; Anti-apoptotic protein which acts by inhibiting the activities of CASP3, CASP7 and CASP9. Can inhibit the autocleavage of pro-CASP9 and cleavage of pro-CASP3 by CASP9. Capable of inhibiting CASP9 autoproteolysis at ’Asp-315’ and decreasing the rate of auto proteolysis at ’Asp-330’. Acts as a mediator of neuronal survival in pathological conditions. Prevents motor- neuron apoptosis induced by a variety of signals. Possible role in the prevention of spinal muscular atrophy that seems to be caused by inappropriate persistence of motor-neuron apopt [...] | 0.500 |
SERF1B | OR4Q3 | ENSP00000370126 | ENSP00000330049 | small EDRK-rich factor 1B (centromeric) | olfactory receptor, family 4, subfamily Q, member 3; Odorant receptor (Potential) | 0.468 |
SERF1B | POTEG | ENSP00000370126 | ENSP00000386971 | small EDRK-rich factor 1B (centromeric) | POTE ankyrin domain family, member G | 0.554 |